Chronic Bronchitis News and Research

RSS

Soy consumption and risk of COPD and respiratory symptoms

People who eat lots of soy products have better lung function and are less likely to develop the smoking-associated lung disease COPD (Chronic Obstructive Pulmonary Disease). A study published in BioMed Central’s open access journal Respiratory Research has shown that consumption of a wide variety of soy products can be associated with a reduction in the risk of COPD and other respiratory symptoms.

28 Jun 2009

Smokers' chronic obstructive pulmonary disease risk is genetic

It's well known that puffing on cigarettes can eventually leave you out of puff.

11 Mar 2009

Newly discovered protein points to new treatment for serious lung disease

The discovery by Uppsala University researchers of a previously unknown protein in the cells of the lower air ways brings new potential for early diagnosis of a serious lung disease.

2 Mar 2009

Call for greater caution in prescribing inhaled corticosteroids to COPD sufferers

Lung disease experts at Johns Hopkins are calling for physicians to show much greater caution in prescribing inhaled corticosteroid drugs for people with chronic obstructive pulmonary disease after finding evidence that the widely used anti-inflammatory medications increase the risk of pneumonia by a full third.

25 Nov 2008

Chronic obstructive pulmonary disease sending more people to hospital

Chronic obstructive pulmonary disease (COPD) has a higher hospitalization rate and a higher hospital readmission rate than heart failure, angina, and other serious chronic diseases.

17 Nov 2008

10 symptoms that should never be ignored

Not every ache and pain merits a quick trip to the doctor -- but some do.

6 Nov 2008

Risk assessment tool finds that blacks with breathing conditions have higher risk for developing lung cancer than whites

Blacks with chronic obstructive pulmonary disease -- including chronic bronchitis and some types of serious chronic asthma -- have a risk for developing lung cancer about twice as high as that of whites with the condition, according to a study published in the journal Cancer Prevention Research, Reuters reports.

10 Sep 2008

Low-level exposure cadmium linked to emphysema

New research suggests that cadmium is one of the critical ingredients causing emphysema, and even low-level exposure attained through second-hand smoke and other means may also increase the chance of developing lung disease.

20 Aug 2008

Premature babies at risk of lung problems later on

According to Australian researchers some premature babies may have a higher risk of developing emphysema and other lung problems later on.

29 Jul 2008

CFC-propelled inhalers no longer available as of Dec. 31 2008

The U.S. Food and Drug Administration today issued a public health advisory to alert patients, caregivers and health care professionals to switch to hydrofluoroalkane (HFA)-propelled albuterol inhalers because chlorofluorocarbon (CFC)-propelled inhalers will not be available in the United States after Dec. 31, 2008.

30 May 2008

Personalized therapy for asthma and chronic obstructive pulmonary disease could soon be here

Researchers at Washington University School of Medicine in St. Louis have defined a new type of immune response that is activated in patients with severe asthma and COPD (chronic obstructive pulmonary disease). Their discovery could dramatically improve diagnosis and treatment of patients with chronic inflammatory lung disease.

19 May 2008

Researchers launch lung cancer screening trial

Scientists are testing a new way of detecting lung cancer at an early stage in people at greatest risk of developing the disease.

9 May 2008

Quit smoking and the benefits soon appear

New research says that people who give up smoking begin to improve their health almost immediately, and the risk of death from all causes falls by 13% within 5 years and to no extra risk of death by 20 years.

7 May 2008

AstraZeneca submits sNDA for SYMBICORT in chronic obstructive pulmonary disease

AstraZeneca today announced that it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for approval of a new indication for SYMBICORT (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of patients with Chronic Obstructive Pulmonary Disease (COPD). SYMBICORT is currently approved for the long-term maintenance treatment of asthma in patients 12 years and older.

30 Apr 2008

Inhibiting stress oxidant may be new therapy for COPD

The study "Oxidative Stress is an Important Component of Airway Inflammation in Mice Exposed to Cigarette Smoke or Lipopolysaccharide" investigates the inflammatory responses in oxidative stress-deficient mice exposed to cigarette smoke.

18 Apr 2008

Asthma and smoker's lung: dry airways play a key role

Dry airways may not only play a central role in the development of the inherited lung disease cystic fibrosis, but also in much more common acquired chronic lung diseases such as asthma and smoker's lung, the cigarette smoke-induced chronic obstructive pulmonary disease (COPD).

8 Apr 2008

Trial of new procedure that may help emphysema suffers

Researchers at Henry Ford Hospital have announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a significant new option for those suffering with advanced emphysema.

13 Mar 2008